tradingkey.logo
tradingkey.logo
Search

Fortrea Holdings Inc

FTRE
Add to Watchlist
19.170USD
+0.090+0.47%
Close 07-31 16:00ETQuotes delayed by 15 min
1.82BMarket Cap
LossP/E TTM

More Details of Fortrea Holdings Inc Company

Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.

Fortrea Holdings Inc Info

Ticker SymbolFTRE
Company nameFortrea Holdings Inc
IPO dateJun 16, 2023
CEOThakrala (Anshul)
Number of employees15500
Security typeOrdinary Share
Fiscal year-endJun 16
Address8 Moore Drive
CityDURHAM
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code27709
Phone18774950816
Websitehttps://www.fortrea.com/
Ticker SymbolFTRE
IPO dateJun 16, 2023
CEOThakrala (Anshul)

Company Executives of Fortrea Holdings Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
246.67K
+60.22%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
91.27K
+42.53%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
91.27K
+42.53%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
84.92K
+45.71%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
75.53K
+8.74%
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Mark Morais
Mr. Mark Morais
Chief Operating Officer and President - Clinical Services
Chief Operating Officer and President - Clinical Services
--
--
Ms. Hima B. Inguva
Ms. Hima B. Inguva
Investor Relations
Investor Relations
--
--
Ms. Erin L. Russell
Ms. Erin L. Russell
Independent Director
Independent Director
--
--
Mr. Anshul Thakrala
Mr. Anshul Thakrala
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
246.67K
+60.22%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
91.27K
+42.53%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
91.27K
+42.53%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
84.92K
+45.71%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
75.53K
+8.74%
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--

FAQs

Who are the top five shareholders of Fortrea Holdings Inc?

The top five shareholders of Fortrea Holdings Inc are: Mr. Peter M. Neupert

How many institutions hold shares of Fortrea Holdings Inc (FTRE)?

As of 2026Q1, 881 institutions hold shares of Fortrea Holdings Inc, with a combined market value of approximately 98.32M, accounting for 103.93% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -25178846.00.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.